Company intelligence / Profile preview

InGef

Berlin, Berlin, Germany

Ownership: Private
Development stage: Other

Overview

InGef conducts practice-oriented research to support the ongoing development of healthcare in Germany. It specializes in analyzing anonymized routine health insurance data to evaluate care models and healthcare system innovations[1][2][3].

The institute leads or partners on several major German healthcare innovation projects such as REVASK, sekTOR-HF, KI-FDZ, and egePan-Unimed[3].
Its proprietary software EVA enables efficient analysis of large-scale health insurance datasets by insurers[2][3].
Results are published regularly and presented at national/international congresses.
No clinical results as it does not conduct clinical trials.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Universities (unspecified academic partners)Various service providers within German healthcareFederal Ministry of Health/Federal Ministry of Economics and Climate Protection (project funding/partnerships)

Beyond the preview

Go deeper on InGef.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InGef.

Explore the full profile